Special Drug Use Investigation of Ciproxan injection in pediatrics
The objective in this study is collecting post-marketing information on the safety and efficacy of Ciproxan injection under the routine clinical practice.
- Female and male pediatric patients (less than 15 years old) with a diagnosis of complicated cystitis, pyelonephritis, cystic fibrosis, or anthrax infected by ciprofloxacin-active microorganisms, i.e. Bacillus anthracis, Escherichia coli, Pseudomonas aeruginosa. - Patients for whom the decision to initiate treatment with Ciproxan injection was made as per investigator’s routine treatment practice.
Many Locations, Japan
E-mail: [email protected]
Phone: (+) 1-888-8422937
Special Drug Use Investigation of Ciproxan® injection in pediatrics